A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI).

To measure the stiffness of the aorta, femoral artery and tibial artery noninvasively, cardio-ankle vascular index (CAVI) which is independent of blood pressure was developed. The formula for measuring this index is; CAVI=a{(2rho/DeltaP) x ln(Ps/Pd)PWV(2)} + b where, Ps and Pd are systolic and diastolic blood pressures respectively, PWV is pulse wave velocity between the heart and ankle, DeltaP is Ps - Pd, rho is blood density, and a and b are constants. This equation was derived from Bramwell-Hill's equation(1)), and stiffness parameter(2)). To elucidate the clinical utility of CAVI, the reproducibility and dependence on blood pressure were studied using VaSera (Fukuda Denshi Co., Ltd.). Furthermore, CAVI in hemodialysis patients with or without atherosclerotic diseases was measured. The average coefficient of variation for five measurements among 22 persons was 3.8%. In hemodialysis patients (n = 482), CAVI was correlated weakly with systolic and diastolic blood pressures (R = 0.175, 0.006), while brachial-ankle PWV was correlated strongly with systolic and diastolic blood pressures (R = 0.463, 0.335). CAVI in hemodialysis patients without signs of atherosclerotic diseases (NA) was 8.1 +/- 0.3 (mean +/- SD). That in patients receiving percutaneous transluminal coronary angioplasty was 8.8 +/- 0.3 (p < 0.05 vs. NA). CAVI in patients with ischemic change in their electrocardiogram (ECG) was 8.5 +/- 0.3 (p < 0.05 vs. NA). That in patients with diabetes mellitus was 8.5 +/- 0.3 (p < 0.002 vs. NA). CAVI in the patients with all three complications was 8.9 +/- 0.35 (p < 0.001 vs. NA). These results suggested that CAVI could reflect arteriosclerosis of the aorta, femoral artery and tibial artery quantitatively.

[1]  T. Kawasaki Noninvasive measurement of common carotid artery effect with echo phase tracking system , 1982 .

[2]  C. Bouchard,et al.  A 12-year follow-up study of treated obese children in Japan , 2002, International Journal of Obesity.

[3]  Alan D. Lopez,et al.  Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study , 1997, The Lancet.

[4]  R. Asmar Pulse wave velocity principles and measurement 25-55 , 1999 .

[5]  K. Shirai,et al.  Effect of nifedipine administration on pulse wave velocity (PWV) of chronic hemodialysis patients—2-year trial , 1990, Cardiovascular Drugs and Therapy.

[6]  S. Matsuoka,et al.  Effect of urapidil on the action potentials in the guinea-pig ventricular myocardium , 1991, Cardiovascular Drugs and Therapy.

[7]  T. Hamazaki,et al.  Comparison of pulse wave velocity of the aorta between inhabitants of fishing and farming villages in Japan. , 1988, Atherosclerosis.

[8]  A. Hill,et al.  The Velocity of the Pulse Wave in Man , 1922 .

[9]  M. Friedrich Epidemic of obesity expands its spread to developing countries. , 2002, JAMA.

[10]  M. Hasegawa Fundamental research on human aortic pulse wave velocity , 1970 .

[11]  K. Murata,et al.  Collagen types in various layers of the human aorta and their changes with the atherosclerotic process. , 1986, Atherosclerosis.

[12]  A. Yamashina,et al.  Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. , 2002, Hypertension research : official journal of the Japanese Society of Hypertension.

[13]  S. Grundy Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. , 1999, The American journal of cardiology.

[14]  G. De Luca,et al.  Structural and functional modifications of human aorta proteoglycans in atherosclerosis. , 1990, Matrix.

[15]  T. Shoji,et al.  Intermediate-density lipoprotein as an independent risk factor for aortic atherosclerosis in hemodialysis patients. , 1998, Journal of the American Society of Nephrology : JASN.